ketoconazole has been researched along with Day Blindness in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, FW | 1 |
| Stiller, RL | 1 |
| South, DA | 1 |
| Stevens, DA | 1 |
| Perlman, EM | 1 |
| Binns, L | 1 |
2 other studies available for ketoconazole and Day Blindness
| Article | Year |
|---|---|
Oral ketoconazole for dermatophyte infections.
Topics: Administration, Oral; Antifungal Agents; Drug Eruptions; Female; Follow-Up Studies; Humans; Imidazol | 1982 |
Intense photophobia caused by Arthrographis kalrae in a contact lens-wearing patient.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Contact Lenses; Cornea; Eye Infections, Fun | 1997 |